| AGTHX | HCMSX | AGTHX / HCMSX | |
| Total Expense Ratio | 0.59 | 2.25 | 26% |
| Annual Report Gross Expense Ratio | 0.59 | 2.76 | 21% |
| Fund Existence | 53 years | 12 years | - |
| Gain YTD | 5.605 | 1.849 | 303% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 357B | 2.03B | 17,604% |
| Annual Yield % from dividends | 0.26 | 0.00 | - |
| Returns for 1 year | 1.64 | 11.07 | 15% |
| Returns for 3 years | 36.13 | 41.50 | 87% |
| Returns for 5 years | 13.69 | 28.08 | 49% |
| Returns for 10 years | 100.57 | 273.63 | 37% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SRV | 46.95 | 1.97 | +4.38% |
| NXG Cushing Midstream Energy Fund | |||
| CLM | 7.44 | 0.12 | +1.64% |
| Cornerstone Strategic Value Fund | |||
| WCAP | 9.13 | 0.10 | +1.16% |
| Warcap Unconstrained Equity ETF | |||
| XUDV | 32.37 | -0.13 | -0.41% |
| Franklin U.S. Dividend Mltplr Idx ETF | |||
| FMED | 28.00 | -0.73 | -2.53% |
| Fidelity Disruptive Medicine ETF | |||